Indivior Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
INDV Nasdaq 2830 www.indivior.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Indivior Pharmaceuticals, Inc.

Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV) - Jun 29th, 2026 9:14 pm
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome - Jun 29th, 2026 9:15 am
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable - Jun 29th, 2026 6:55 am
Bull of the Day: Neurocrine Biosciences (NBIX) - Jun 29th, 2026 2:00 am
IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati - Jun 26th, 2026 8:43 am
Kymera Jumps 17% on Early Enrollment Completion in Skin Disease Study - Jun 26th, 2026 8:28 am
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - Jun 26th, 2026 2:59 am
IBD 50 Stock Indivior Breaks Out Amid Big Fund Ownership Expansion, Strong Profit Prospects - Jun 25th, 2026 9:24 am
Reasons Why Investors Should Consider Betting on Indivior Stock - Jun 25th, 2026 7:27 am
5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Jun 25th, 2026 6:40 am
RVMD Starts Treatment in Phase III Pancreatic Cancer Study on Zoldonrasib - Jun 24th, 2026 8:13 am
GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH - Jun 24th, 2026 8:05 am
Xenon Pharmaceuticals Stock Gains 22% in Six Months: Here's Why - Jun 23rd, 2026 8:59 am
Definium Stock Soars 50% as Phase III Depression Study Meets Key Goals - Jun 23rd, 2026 8:52 am
BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for Phenylketonuria - Jun 19th, 2026 8:35 am
Can Vertex's Kidney Pipeline Power Its Next Growth Phase? - Jun 19th, 2026 6:14 am
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing - Jun 19th, 2026 6:04 am
AGIO Stock Surges 35% in Six Months: What's Driving It? - Jun 18th, 2026 9:24 am
Corcept Resubmits NDA for Relacorilant in Cushing's Syndrome - Jun 18th, 2026 7:57 am
MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns - Jun 17th, 2026 9:11 am